Dr. Linlin Wang 王琳琳
Chief Physician
Department of Thoracic Radiation Oncology I, Cancer Hospital of Shandong First Medical University (Shandong Cancer Hospital), Jinan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of common thoracic tumors, including lung cancer, esophageal cancer, and breast cancer.
Dr. Wang is Chief Physician and Head of the Third Ward, Thoracic Radiotherapy, at Shandong Cancer Hospital. A postdoctoral fellow in oncology and former visiting scholar in Australia, Dr. Wang trained under Academician Yu Jinming. With over 10 years of experience, Dr. Wang has published over 40 articles, including more than 30 SCI-indexed papers, and holds one national invention patent.
Professional roles
- Member, Tumor Molecular Markers and Targeted Therapy Professional Committee, Shandong Immunology Society
- Member, Biological Targeted Therapy Professional Committee, Shandong Geriatrics Society
- Member, Youth Collaboration Group, Tumor Precision Medicine Branch, Shandong Medical Doctor Association
- Member, Palliative Care Subcommittee, Beijing Cancer Prevention and Treatment Research Association
Name order: in Chinese the family name comes first (Wang Linlin). Papers usually list the name as Linlin Wang or Wang L.
Selected publications
142 papers on PubMed matched by name and affiliation; 90 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int Immunopharmacol, 2026 (senior author): Golidocitinib ameliorates radio-immunotherapy-induced lung injury by alleviating oxidative stress and Pyroptosis. PubMed 42854381
- Ultrasound Med Biol, 2026 (senior author): Adaptive Positioning and Targeting Optimization in Transcranial Focused Ultrasound (tFUS): A Numerical Study. PubMed 42754450
- Cancer Lett, 2026 (first author): Chinese expert consensus on radiotherapy combined with immunotherapy for unresectable lung cancer (2026 Edition). PubMed 42413815
- Int J Cancer, 2026 (senior author): Chemoimmunotherapy With or Without Thoracic Radiotherapy for Elderly Patients in Advanced Non-Small Cell Lung Cancer. PubMed 42121314
- Int J Radiat Oncol Biol Phys, 2026 (senior author): Prophylactic Recombinant Human Thrombopoietin Prevents Cancer Therapy-Induced Thrombocytopenia During Concurrent Chemoradiation Therapy in Limited-Stage Small Cell Lung Cancer: A Prospective, Multicenter, Phase II Clinical Trial. PubMed 41831791
- iScience, 2026 (senior author): Efficacy and safety of adding induction therapy for unresectable NSCLC receiving cCRT and consolidation immunotherapy: A retrospective study. PubMed 42621211
- Int J Cancer, 2026 (senior author): Impact of lymphatic ablation approaches on immunotherapy efficacy in advanced/metastatic esophageal squamous cell carcinoma: A multi-institutional retrospective cohort study. PubMed 41872730
- J Chem Inf Model, 2026 (senior author): Deep Learning-Driven Anticancer Drug Discovery: Emodepside as a Potential Therapeutic Candidate for Triple-Negative Breast Cancer. PubMed 42486779
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion